Nonetheless, a recent study by Kurtovic et al. [21] has shown that anti‐CSP antibodies from malaria‐exposed populations that were predominately IgG1, IgG3, and IgM can fix complement and hence activate the classical pathway. The gene discussed is CD40LG; the disease is malaria.